ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01433497
Brief Title: A Phase 3 Study to Compare Efficacy and Safety of Masitinib to Placebo in the Treatment of Patients With Primary Progressive or Relapse-free Secondary Progressive Multiple Sclerosis

First Submitted : September 12, 2011
First Submitted that Met QC Criteria : September 13, 2011
First Posted : September 14, 2011 (Estimate)

Last Update Submitted that Met QC Criteria : April 20, 2017
Last Update Posted : April 21, 2017